Skip to content
Wenlo
Sign in
← Markets

CG Oncology Inc.

Isabel Kalofonos (Chief Commercial Officer) reports CGON insider transactions

4CGONFiled Oct 19, 2026, 12:30 PM ET· Period Oct 15, 2026

About this filing

CG Oncology Inc. (CGON) filed Form 4 (insider transaction) with the SEC on Oct 19, 2026. Form 4 reports a company insider’s trades in the company’s shares.

Key facts

Insider
Isabel Kalofonos · Chief Commercial Officer
DateTransactionSharesPriceValueHeld afterOwnership
Oct 15, 2026A · grantEmployee Stock Option (right to buy)Footnotes F1+92,000$0.00$0.0092,000Direct
Footnotes
  1. F1 The stock option vests over a four-year period starting on October 13, 2026 (the "Vesting Commencement Date"), with 25% of the shares vesting on the date that is twelve months after the Vesting Commencement Date and the remainder vesting in thirty-six equal monthly installments over the subsequent three-year period, subject to the Reporting Person's continuous service to the Issuer through each vesting date.

More CGON filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.